HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: AAD on AHAs

This article was originally published in The Rose Sheet

Executive Summary

AAD on AHAs: American Academy of Dermatology's Chemical Peel Task Force is waiting for data from FDA's Consumer Cosmetics Adverse Reaction Hotline before it will release its guidelines on chemical peels. FDA said it still plans to have the hotline up and running later this summer. Originally slated for publication this year, the guidelines are now expected to be released in 1996. The guidelines will include the task force's findings on chemical peels, including the group's opinion that concentrations of alpha hydroxy acids used in consumer products are safe, with only minor side effects ("The Rose Sheet" March 6, p. 1)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001791

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel